CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale Director sold 10,000 shares at $34.63 ($346,300)
- 4 Open-market sale SVP & Chief Financial Officer sold 25,000 shares at $33.71 ($842,750)
- 4 Open-market sale President & CEO sold 100,000 shares at an average $33.00 ($3,300,000)
- 4 Open-market sale SVP & Chief Accounting Officer sold 1,928 shares at $31.37 ($60,481)
- 4 Open-market sale President & CEO sold 13,383 shares at $31.37 ($419,825)
- 4 Open-market sale SVP & Chief Operating Officer sold 4,077 shares at $31.37 ($127,895)
- 4 Open-market sale SVP & Chief Financial Officer sold 3,767 shares at $31.37 ($118,171)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,449 shares at $31.37 ($76,825)
- 4 Open-market sale SVP & Chief Scientific Officer sold 3,461 shares at $31.37 ($108,572)
- 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
- 4 Open-market sale SVP & Chief Accounting Officer sold 1,808 shares at $42.39 ($76,641)
- 4 Open-market sale President & CEO sold 108,882 shares at an average $42.19 ($4,594,176)
- 4 Open-market sale SVP & Chief Operating Officer sold 3,822 shares at $42.39 ($162,015)
- 4 Open-market sale SVP & Chief Financial Officer sold 3,592 shares at $42.39 ($152,265)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,386 shares at $42.39 ($101,143)
- 4 Open-market sale SVP & Chief Scientific Officer sold 3,310 shares at $42.39 ($140,311)
- 4 Open-market sale SVP & Chief Accounting Officer sold 16,119 shares at $42.16 ($679,577)
- 4 Open-market sale SVP & Chief Operating Officer sold 63,000 shares at $42.82 ($2,697,660)
- 4 Grant or award SVP & Chief Accounting Officer acquired 10,950 shares (grant or award)
- 4 Grant or award President & CEO acquired 68,450 shares (grant or award)
Page 15 of 49 · 970 filings